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To the Editor: We read with great interest the 
Matsumura et al. paper describing extended-spectrum 
β-lactamase (ESBL) CTX-M-27–producing Escherichia 
coli of sequence type (ST) 131 clonal group, an emerging 
clade called C1-M27 (1). ST131 E. coli having blaCTX-M-27 
has been described in several countries. We observed an 
alarming increase of this clonal group in the fecal carriage 
of children in France (0% in 2010 to 65% in 2015 among 
ESBL-producing ST131 E. coli) (2). 
We wondered whether this clonal group’s expansion 
in France was attributable to the same clade (C1-M27). For 
that, we designed primers (M27PP1-B-F, 5′-TTACTCC-
GACTATGCGTTCAC-3′; M27PP1-B-R, 5′-CAAACTT-
GCCCCTGATAGCG-3′; amplicon length, 1.5 kb) to amplify 
the insertion site of the structure comprising the direct repeat 
and prophage-like genomic island of E. coli PCN033, as pre-
viously described (1). PCR was performed on our recently 
described collection of 39 ESBL-producing ST131 E. coli, 
including 16 CTX-M-27–producing E. coli: 13 of subgroup 
O25b with fimH30 allele and 3 of O16 subgroup with fimH41 
allele (2). Results showed that 81% (13/16) of the CTX-M-27–
producing E. coli ST131 had the M27PP1 structure, similar to 
strain PCN033, and thus belong to the C1-M27 clade. There-
fore, the C1-M27 clade found in Asia and America is also 
present in Europe in the fecal flora of young children. The 3 
isolates belonging to the O16 subgroup with fimH41 lacked 
M27PP1, suggesting that blaCTX-M-27 might diffuse among non-
H30 ST131 E. coli without this prophage-like genomic island. 
Finally, the non–CTX-M-27–producing ST131 E. coli of our 
collection were negative for M27PP1 elements.
Our results show that CTX-M-27–producing E. coli 
ST131 subgroup O25b with fimH30 allele (one third of the 
ESBL-producing ST131 carriage isolates) isolated from 
children in France belong to C1-M27 and that CTX-M-27–
producing O16 strains display distinct genetic characteris-
tics. Altogether, our data confirm the worldwide distribution 
of C1-M27 and its high prevalence in children in France.
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To the Editor: The Kassem et al. article regarding 
high rates of multidrug-resistant (MDR) bacteria coloniz-
ing Syrian children highlights the challenge of choosing 
empiric antimicrobial drugs to treat war-injured refugees 
from Syria (1). The findings mirror other reports (2,3) and 
our own experience in a charitable hospital in Amman, 
Jordan, which manages war-injured refugees from Syria. 
As part of a program of antimicrobial drug stewardship 
and infection prevention and control, empiric antimicro-
bial drug protocols were introduced. For antimicrobial 
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drug–naive patients, the first-line choice for prophylaxis 
and treatment of skin and soft-tissue infections, including 
those involving open fractures, was a narrow-spectrum 
cephalosporin, as recommended by the Infectious Diseas-
es Society of America guidelines (4); however, clinical 
failure was common.
We retrospectively reviewed the clinical microbiology 
data of 75 patients admitted in January 2015 with a history 
of suspected post-trauma infection. All these patients were 
first treated in field hospitals in Syria; 82.7% were male, 
and 33% were <16 years old. Twenty-four percent had mul-
tiple injuries, 20% had osteomyelitis, and 53% had metal 
prosthetic implants.
Thirty bacterial isolates were identified, mostly from 
deep wound swabs of 21 (28%) injured patients; 9/21 were 
infected with 2 isolates. Twenty-nine (97%) isolates were 
gram-negative bacteria: 10 Proteus spp., 10 Escherichia 
coli, 5 Pseudomonas spp., and 4 Klebsiella spp. Disk dif-
fusion susceptibility testing showed that 20 (66%) isolates 
were MDR and 11 (36.7%) were carbapenem resistant. 
The hospital laboratory did not have the capacity 
to perform further testing and confirmation of the resis-
tant strains in line with international quality standards 
because they lacked suitable equipment and financial 
resources. Preventing further dissemination of MDR 
organisms among war-injured refugees from Syria at 
hosting healthcare facilities requires an effective sur-
veillance system, investment in infection prevention and 
control, appropriate antimicrobial drug stewardship, and 
urgent laboratory capacity building inside Syria and in 
the refugee-host countries.
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Frederic Remington was an American  
painter, sculptor, illustrator, and writer 
whose works frequently featured cowboys,  
Native Americans, soldiers, horses, bison, 
and other iconic features of the rapidly  
vanishing American West. This issue's cover 
painting, commonly known as The Cigarette,  
was discovered in Remington’s studio after 
his death. In this painting, four cowboys re-
lax around a small outside a cabin. A plume 
of smoke rises toward the clear blue-green 
night sky flecked with a few stars, past a 
large skin hanging on the side of the cabin. 
The cabin does not overwhelm the painting 
but details such as the shadow under the 
roofline, the seams between logs, the soft-
ened edges of the structure, and the tautly 
stretched skin reveal Remington’s deftness 
at rendering textures. His use of subdued 
colors punctuated by the reflected firelight  
underscores the quiet of the evening’s  
respite following a long day’s work.
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